In a preclinical model of mice bearing lung carcinoma, paclitaxel has been demonstrated to selectively inhibit CD4+FOXP3+ Treg cells, but not other CD4+FOXP3- T helper cells [22]. Here, CD4 is linked to lung carcinoma.